Disc Medicine (IRON) Other Accumulated Expenses (2020 - 2026)
Disc Medicine's (IRON) quarterly Other Accumulated Expenses came in at $870000.0 in Q1 2026, up 71.6% year-on-year from $507000.0 in Q1 2025, and up 23.4% on a QoQ basis from $705000.0 in Q4 2025.
Disc Medicine (IRON) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Other Accumulated Expenses data on file, last reported at $870000.0 in Q1 2026.
- On a quarterly basis, Other Accumulated Expenses rose 71.6% year-over-year to $870000.0 in Q1 2026; TTM through Mar 2026 was $870000.0, a 71.6% increase from a year earlier, with the FY2025 full-year figure at $705000.0, up 98.59% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $870000.0, up from $705000.0 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for IRON reached as high as $870000.0 in Q1 2026 and fell as low as $52000.0 in Q4 2023.
- Historically, Other Accumulated Expenses has averaged $390428.6 across 5 years, with a median of $291000.0 in 2023.
- Across the five-year window, Other Accumulated Expenses soared 880.95% in 2022 and tumbled 74.76% in 2023, its largest moves.
- Year by year, Other Accumulated Expenses stood at $206000.0 in 2022, then tumbled by 74.76% to $52000.0 in 2023, then surged by 582.69% to $355000.0 in 2024, then surged by 98.59% to $705000.0 in 2025, then increased by 23.4% to $870000.0 in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $870000.0 in Q1 2026, $705000.0 in Q4 2025, and $749000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Disc Medicine | 2.89 Bn | 2.89 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 870,000.00 |
| Dec 31, 2025 | 705,000.00 |
| Sep 30, 2025 | 749,000.00 |
| Jun 30, 2025 | 810,000.00 |
| Mar 31, 2025 | 507,000.00 |
| Dec 31, 2024 | 355,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Mar 31, 2024 | 199,000.00 |
| Dec 31, 2023 | 52,000.00 |
| Sep 30, 2023 | 54,000.00 |
| Jun 30, 2023 | 189,000.00 |
| Mar 31, 2023 | 345,000.00 |
| Dec 31, 2022 | 206,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 147,000.00 |
| Mar 31, 2021 | 87,000.00 |
| Dec 31, 2020 | 46,000.00 |